[go: up one dir, main page]

WO2012061536A3 - Méthodes de traitement de troubles capillaires - Google Patents

Méthodes de traitement de troubles capillaires Download PDF

Info

Publication number
WO2012061536A3
WO2012061536A3 PCT/US2011/059027 US2011059027W WO2012061536A3 WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3 US 2011059027 W US2011059027 W US 2011059027W WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
hair loss
treating hair
loss disorders
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/059027
Other languages
English (en)
Other versions
WO2012061536A2 (fr
Inventor
Angela M. Christiano
Raphael Clynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Publication of WO2012061536A2 publication Critical patent/WO2012061536A2/fr
Anticipated expiration legal-status Critical
Publication of WO2012061536A3 publication Critical patent/WO2012061536A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des méthodes de traitement de troubles capillaires chez un sujet par l'administration d'un inhibiteur de NKG2D, d'un inhibiteur d'IL-15 ou d'une combinaison de ceux-ci.
PCT/US2011/059027 2010-11-02 2011-11-02 Méthodes de traitement de troubles capillaires Ceased WO2012061536A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40951410P 2010-11-02 2010-11-02
US61/409,514 2010-11-02

Publications (2)

Publication Number Publication Date
WO2012061536A2 WO2012061536A2 (fr) 2012-05-10
WO2012061536A3 true WO2012061536A3 (fr) 2014-04-10

Family

ID=46025095

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/059027 Ceased WO2012061536A2 (fr) 2010-11-02 2011-11-02 Méthodes de traitement de troubles capillaires

Country Status (1)

Country Link
WO (1) WO2012061536A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102993097A (zh) * 2012-11-09 2013-03-27 贵州大学 吡唑酰胺类化合物及其应用
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
US12459980B2 (en) 2018-07-25 2025-11-04 AskGene Pharma, Inc. IL-21 prodrugs and methods of use thereof
CN114341189A (zh) 2019-06-12 2022-04-12 奥美药业有限公司 全新il-15前药及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080069791A1 (en) * 2003-12-29 2008-03-20 Universitaetsklinikum Muenster Means for stimulation and activation of hair growth by il-15

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080069791A1 (en) * 2003-12-29 2008-03-20 Universitaetsklinikum Muenster Means for stimulation and activation of hair growth by il-15

Also Published As

Publication number Publication date
WO2012061536A2 (fr) 2012-05-10

Similar Documents

Publication Publication Date Title
WO2012061537A3 (fr) Méthodes de traitement de troubles capillaires
WO2012006538A8 (fr) N-éthyl-n-phényl-1,2-dihydro-4-hydroxy-5-chloro-1-méthyl-2-oxoquinoléine-3-carboxamide deutéré, sels de ce composé et utilisations correspondantes
PT2649242E (pt) Processo para a construção de estruturas, nomeadamente passagens sob ferrovias em funcionamento ou similares
WO2013046060A9 (fr) Papier et procédés de fabrication du papier
WO2014042433A3 (fr) Composés et compositions de modulation de l'activité du récepteur adénosine a3
WO2014035140A3 (fr) Composés et compositions pour la modulation de l'activité histone méthyltransférase
WO2012166626A8 (fr) Réactifs et procédés pour traiter une maladie dentaire
WO2013177055A3 (fr) Anticorps et immunoconjugués anti-ly6e et procédés d'utilisation
WO2011075636A3 (fr) Épitopes et agents de liaison destinés à wise
WO2012103393A3 (fr) Lutte contre les cochenilles
MY151551A (en) Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
WO2011133504A3 (fr) Nanozymes, procédés de production de nanozymes, et procédés d'utilisation de nanozymes
EP2729464B8 (fr) 1,3-thiazépines à cyclopropyle fusionné en tant qu'inhibiteurs de bace 1 et/ou de bace 2
WO2013023151A3 (fr) Compositions et méthodes de traitement de maladie cœliaque
WO2011130347A3 (fr) Procédés d'amélioration d'une régénération axonale
WO2012064743A3 (fr) Procédés d'amélioration de la fonction cardiaque
WO2011083483A3 (fr) Procédé pour traiter une maladie et un trouble inflammatoires
WO2012061536A3 (fr) Méthodes de traitement de troubles capillaires
WO2013016280A3 (fr) Compositions et procédés pour sélectionner des aptamères
WO2012154533A3 (fr) Lutte contre les fulgores
WO2011110624A3 (fr) β-HYDROXYALKYLAMIDES, PROCÉDÉ POUR LES PRODUIRE ET LEUR UTILISATION
WO2011133893A3 (fr) Antidotes du cyanure
WO2011011733A3 (fr) Thérapie de remplacement de facteur
WO2012174280A3 (fr) Méthodes et compositions permettant de moduler l'activité des myofibroblastes
ZA201404986B (en) Methods for preventing, treating or diagnosing disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11838770

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 11838770

Country of ref document: EP

Kind code of ref document: A2